Drug intelligence / Profile preview

BK011

Development stage: Unknown
Lead developer: Zhejiang Xinweishengke Biotechnology
Modality: Monoclonal Antibodies → Antibody-Based Therapeutics
Administration: Intravenous

Overview

BK011 (Weituo) is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody developed by Zhejiang Xinwei Shengke Biotechnology. It is designed to target the Epidermal Growth Factor Receptor (EGFR), a transmembrane protein that is frequently overexpressed in various solid tumors and plays a critical role in cell proliferation, survival, and metastasis. By binding to the extracellular domain of EGFR, BK011 inhibits the activation of downstream signaling pathways. The drug is currently being evaluated in Phase 1 clinical trials to assess its safety, tolerability, pharmacokinetics, and preliminary antitumor activity in patients with advanced malignant solid tumors, with a specific focus on esophagogastric cancers that have failed standard therapies.

Brand names: Weituo
Other names: recombinant anti-EGFR human-mouse chimeric monoclonal antibody

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on BK011.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BK011.

Explore the full profile